Project information
Tumor heterogeneity, immune dysfunction and therapy resistance are among the most substantial challenges that limit durable benefit of cancer (immuno)therapies. Using powerful function-based genomics, we screen for novel therapeutic targets to tackle those clinical problems. In this way we develop new concepts for rational combination treatments, which target both tumor and immune cells, thereby simultaneously eliminating the patient’s tumor and harnessing its immune system. This has already culminated in discoveries that we aim to translate to the benefit of the patient.
For this position, we seek a bioinformatician who will collaborate with wet lab PhD students and postdocs on genetic screen analysis, clinical data analysis and related bioinformatic questions. Furthermore, you will be responsible for building and maintaining genomic analysis pipelines, using the latest best practices. 

Your profile: an ambitious bioinformatician.

We are seeking an enthusiastic and ambitious bioinformatician with a Master degree and a strong interest in cancer biology, (functional) oncogenomics and (immuno)therapy resistance. A solid understanding of basic statistics for bioinformatics is required. Proficiency in English and good communicative skills are also important requirements, as is a team player mentality. 

Fixed-term contract: 2 years.

The vacancy is available immediately. You will be employed for a period of at least 2 years. The gross salary per month is € 2.882 to € 4.227 according to the salary scale FWG 55, and depends on previous experience. The terms of employment will be in accordance with the CAO Hospitals. 
In addition you will receive a fixed end-of-year bonus in December (8,33%) and in May you will receive 8,33% holiday pay. For more information in regard to the secondary conditions please visit our website: https://www.nki.nl/careers-study/how-to-apply/.

Netherlands Cancer Institute (NKI)

Located in Amsterdam, NKI is the only comprehensive cancer center in The Netherlands. It is a well-organized and dynamic institute accommodating over 50 research groups and many advanced core facilities. It is an internationally renowned center dedicated to fundamental, translational and clinical cancer research.